Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications

BACKGROUND: The National Medical Products Administration (NMPA) in China has set to advance the regulatory capacity of traditional Chinese medicines (TCMs) with the adoption of regulatory science (RS). However, the priority of actions at the interface of RS and TCMs were yet to be defined. This rese...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Zuanji, Lai, Yunfeng, Li, Meng, Shi, Junnan, Lei, Chi Ieong, Hu, Hao, Ung, Carolina Oi Lam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884970/
https://www.ncbi.nlm.nih.gov/pubmed/33593397
http://dx.doi.org/10.1186/s13020-021-00433-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884970/
https://www.ncbi.nlm.nih.gov/pubmed/33593397
http://dx.doi.org/10.1186/s13020-021-00433-2

Ejemplares similares